Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun:83:245-51.
doi: 10.1016/j.freeradbiomed.2015.03.004. Epub 2015 Mar 12.

Reinterpreting the best biomarker of oxidative stress: The 8-iso-PGF(2α)/PGF(2α) ratio distinguishes chemical from enzymatic lipid peroxidation

Affiliations

Reinterpreting the best biomarker of oxidative stress: The 8-iso-PGF(2α)/PGF(2α) ratio distinguishes chemical from enzymatic lipid peroxidation

Thomas J van 't Erve et al. Free Radic Biol Med. 2015 Jun.

Abstract

The biomarker 8-iso-prostaglandin F2α (8-iso-PGF2α) is regarded as the gold standard for detection of excessive chemical lipid peroxidation in humans. However, biosynthesis of 8-iso-PGF2α via enzymatic lipid peroxidation by prostaglandin-endoperoxide synthases (PGHSs), which are significantly induced in inflammation, could lead to incorrect biomarker interpretation. To resolve the ambiguity with this biomarker, the ratio of 8-iso-PGF2α to prostaglandin F2α (PGF2α) is established as a quantitative measure to distinguish enzymatic from chemical lipid peroxidation in vitro, in animal models, and in humans. Using this method, we find that chemical lipid peroxidation contributes only 3% to the total 8-iso-PGF2α in the plasma of rats. In contrast, the 8-iso-PGF2α levels in plasma of human males are generated >99% by chemical lipid peroxidation. This establishes the potential for an alternate pathway of biomarker synthesis, and draws into question the source of increases in 8-iso-PGF2α seen in many human diseases. In conclusion, increases in 8-iso-PGF2α do not necessarily reflect increases in oxidative stress; therefore, past studies using 8-iso-PGF2α as a marker of oxidative stress may have been misinterpreted. The 8-iso-PGF2α/PGF2α ratio can be used to distinguish biomarker synthesis pathways and thus confirm the potential change in oxidative stress in the myriad of disease and chemical exposures known to induce 8-iso-PGF2α.

Keywords: Biomarkers; F(2)-isoprostanes; Inflammation; Lipid peroxidation; Oxidative stress.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. PGHS-2 produces 8-iso-PGF at a ratio of 0.004 in relation to PGF; this ratio is constant regardless of enzyme activity
A: The absolute amounts of 8-iso-PGF and PGF increase linearly with induction of PGHS-2 activity. B: The ratio between the two products does not change significantly. C: The absolute amounts of 8-iso-PGF and PGF are decreased with inhibition of PGHS-2 enzyme activity by meclofenamic acid (66 and 75% inhibition for PGF and 8-iso-PGF, respectively). D: The 8-iso-PGF / PGF ratio is not altered significantly from control with inhibition of PGHS-2 enzyme activity with meclofenamic acid. E: The absolute amounts of 8-iso-PGF and PGF are decreased with inhibition of PGHS-2 enzyme activity by indomethacin (72% inhibition for both PGF and 8-iso-PGF). F: The ratio between PGF and 8-iso-PGF is not altered significantly with inhibition of PGHS-2 enzyme activity with indomethacin.
Fig. 2
Fig. 2. The ratio of 8-iso-PGF to PGF is a highly sensitive and selective measure of increased chemical lipid peroxidation
A: Arachidonic acid incubated with the water-soluble free radical generator AAPH produces near equal amounts of 8-iso-PGF and PGF. B: A mathematical simulation of the 8-iso-PGF / PGF ratio when chemical lipid peroxidation (CLP) is varied relative to the prostaglandin-endoperoxide synthases (PGHS-1 & PGHS-2). The expression of PGHS-2 is varied in three distinct ratios with respect to PGHS-1 to simulate the effect of enzyme induction on the 8-iso-PGF / PGF ratio. The equation of this model (Equation 2) can be used to determine the relative contributions of both pathways to the measured 8-iso-PGF levels.
Fig 3
Fig 3. 8-iso-PGF is mainly a product of enzymatic lipid peroxidation in male fisher 344 rats and mostly of chemical lipid peroxidation in healthy human males
A: 8-iso-PGF and PGF were measured in the plasma of 4 untreated rats, and the ratio between the two compounds calculated (Ratiorat plasma = 0.06 ± 0.02; mean ± SE). B: Using Equation 2, at baseline, the source of the measured 8-iso-PGF in rat plasma is mainly from PGHS (96.7 ± 1.5 % of total); 3.3 ± 1.5 % comes from chemical lipid peroxidation (CLP). C: 8-iso-PGF and PGF were measured in the plasma of 4 healthy nonsmoking human males. The levels for each individual are reported as mean ± SE. D: The ratio between 8-iso-PGF and PGF in human plasma is 0.88 ± 0.26 (mean ± SE). E: Using Equation 2, at baseline, the source of the measured 8-iso-PGF in human plasma is mainly from CLP (99.5 ± 0.5 % of total); 0.5 ± 0.5 % comes from PGHSs.
Scheme 1
Scheme 1
The peroxidation of arachidonic acid with the chemical structures of intermediates and products integral to this study.

Similar articles

Cited by

References

    1. Pratico D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med. 1998;4:1189–1192. - PubMed
    1. Keaney JF, Jr, Larson MG, Vasan RS, Wilson PWF, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol. 2003;23:434–439. - PubMed
    1. Murer SB, Aeberli I, Braegger CP, Gittermann M, Hersberger M, Leonard SW, Taylor AW, Traber MG, Zimmermann MB. Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents. J Nutr. 2014;144:193–201. - PubMed
    1. Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ, II, Rokach J, Shigenaga MK, Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP, Barrett J. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med. 2005;38:698–710. - PubMed
    1. Kadiiska MB, Gladen BC, Baird DD, Graham LB, Parker CE, Ames BN, Basu S, Fitzgerald GA, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ, II, Rokach J, Shigenaga MK, Sun J, Walter PB, Tomer KB, Barrett JC, Mason RP. Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med. 2005;38:711–718. - PubMed

Publication types